Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MREO - Mereo BioPharma: Anti-TIGIT Developer In Mid-Stage Development

MREO - Mereo BioPharma: Anti-TIGIT Developer In Mid-Stage Development

Mereo BioPharma Group
  • MREO is a British company developing a new kind of monoclonal antibody for cancer.
  • The company's self-owned pipeline is in the early stage.
  • They recently announced interim data from a phase 1b trial.

For further details see:

Mereo BioPharma: Anti-TIGIT Developer In Mid-Stage Development
Stock Information
Company Name: Mereo BioPharma Group
Stock Symbol: MREO
Market: NASDAQ
Website: mereobiopharma.com
Menu
MREO MREO Quote MREO Short MREO News MREO Articles MREO Message Board
Get MREO Alerts

News, Short Squeeze, Breakout and More Instantly...